Validated Assays and Assay Services
DCTD develops and validates assays for their intended use (i.e., preclinical and clinical), as well as provides assay services to the research community.
Accessing Assays and Assay Services
-
Clinical Pharmacodynamic Biomarker Assays
Validated, pharmacodynamic-based SOPs of historical biomarkers, NCLN-endorsed, and additional supported assays for DCTD-sponsored trials.
-
Proteomic Assays
Centralized location of highly characterized proteomic assays, validated data, and related SOPs.
-
Assay Cascade Characterization Service
Free assay cascade characterization service from the Nanotechnology Characterization Lab to determine nanoparticles' physical and chemical properties, and compatibility with biological systems.
-
High-Throughput Screening Services
Publicly available antitumor high-throughput screening assays in 2-D (NCI-60) and 3-D (patient-derived organoid) platforms.
Additional Assay Resources
-
Assay Harmonization Activities and Resources
Researchers have access to funding opportunities and recommendations on harmonization requirements and approaches to help make clinical test results comparable between different assay locations.
-
Essential Assays in Clinical Trials
Recommended integrated assay standards for clinical trial protocols, specifically expectations for in vitro and imaging test performance.